Skip to main content

Quick links menu

edited by AIFA’s Office of Osmed and HTA

Glossary


RISK SHARING SCHEMES
Agreements concluded by payers and pharmaceutical companies to diminish the impact on the payer's budget of new and existing medicines brought about by either the uncertainty of the value of the medicine and/or the need to work within finite budgets. [Source: Adamski J. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Services Research 2010, 10:153.] See also: managed entry agreements A contract between two parties who agree to engage in a transaction in which there are uncertainties regardless concerning its final value. Nevertheless, one party, the company, has sufficient confidence in its claims of either effectiveness or efficiency that it is ready to accept a reward or a penalty depending on the observed performance of its product. [Source: de Pourville G.Risk-sharing arrangements for innovative drugs. A new solution to old problems. Eur J Health Econ 2006, 7:155-7.] See also: managed entry agreements
Skip to main content Skip to the top of the page